Methodology

Quantitative

Publications

Examining the association between fentanyl use and perceived adequacy of methadone dose: a retrospective cohort study

Young S, Raboud J, Dodd Z, DeBeck K, Milloy MJ, Wilson D, Hayashi K, Bayoumi AM, Fairbairn N, Drug Alcohol Depend

Barriers and facilitators to accessing opioid agonist therapy for street-involved adolescents and young adults in Vancouver

Gallant K, Nijjar P, DeBeck K, Cui M, Kerr T, J Addict Med

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study

Bouthillier A, Bastien G, McAnulty C, Bakouni H, Le Foll B, Socias ME, Jutras-Aswad D., Harm Reduct J. 2025

Cannabis use and illicit opioid cessation among people who use drugs living with chronic pain

Kitchen C, Socías ME, Sayre EC, Hayashi K, DeBeck K, Milloy MJ, Kerr T, Reddon H, Drug Alcohol Rev

Differences in overdose rates by gender at supervised consumption services: an explanatory sequential mixed methods study

Muel, E., Fan, E., Ginn, C., & Jackson, J., Drugs: Education, Prevention and Policy

Five‑Year Outcomes of a School‑Based Personality‑Focused Prevention Program on Adolescent Substance Use Disorder: A Cluster Randomized Trial

Patricia Conrod, Sherry H. Stewart, Jean Séguin, Robert Pihl, Benoit Masse, Sean Spinney, Samantha Lynch, American Journal of Psychiatry, 2025

Changes in the Sex/Gender Gap in Cannabis Use in Ontario, Canada From 2001 to 2019

Matheson, J., Yeshambel, N., Elton-Marshall, T., Rueda, S., Ali, F., Hamilton, H.A., Rehm, J., Le Foll, B., Imtiaz, S., Drug and Alcohol Review

The effects of a provincial opioid prescribing standard on prescribing for pain in adults: an interrupted time‑series analysis

Dimitra Panagiotoglou, Sandra Peterson, M. Ruth Lavergne, Tara Gomes, Rashmi Chadha, Philippa Hawley, Rita McCracken, Canadian Medical Association Journal (CMAJ), 2025

Binge Drug Injection in a Cohort of People Who Inject Drugs in Montreal: Characterizing the Substances and Social Contexts Involved

Nanor Minoyan, Stine Bordier Høj, Didier Jutras‑Aswad, Sarah Larney, Valérie Martel‑Laferrière, Marie‑Pierre Sylvestre, Julie Bruneau, International Journal of Mental Health and Addiction, 2025

Examining opioid agonist treatment (OAT) site operations and early signals of change in the first year of British Columbia’s drug decriminalization policy: Insights from a provincial survey

Russell,C., Law, J., Hodgson, K., Mackinnon, L., Shahin, R., Crichlow, F., Patenaude, S., Imtiaz, S., Rhem, J., Ali, F., Canadian Journal of Public Health

Overall and substance use-specific healthcare utilization among individuals with and without criminal justice involvement in Ontario, Canada

Russell, C., Yakubovich, A., O’Campo, P., Qu, K., Pluptre, L., Kouyoumdjian, F., Matheson, F. I., Int J Prison Health

Primary care physician characteristics associated with becoming opioid agonist treatment prescribers in British Columbia: a retrospective case‑control study

Dimitra Panagiotoglou, Sandra Peterson, M. Ruth Lavergne, Tara Gomes, Rashmi Chadha, Cheyenne Johnson, Rita McCracken, Harm Reduction Journal, 2025

Exploring Pain‑Severity and Psychological‑Flexibility Trajectories During Group‑Based Psychotherapy for Chronic Pain

Élisabeth Lamoureux, Karen Ghoussoub, Yoram Shir, Marc O. Martel, Zakhar Prylutskyy, M. Gabrielle Pagé, International Journal of Group Psychotherapy, 2025

Characterizing changes to harm reduction site operations in British Columbia following the implementation of the decriminalization of drugs: Findings from a provincial survey

Ali, F. , Russell,C., Law, J., Imtiaz, S., Budau, J., Shahin, R., MacKinnon, L., Griffith, S., Patenaude, S., Xavier, J., Rhem, J., Harm Reduction Journal

Exploring unregulated substance use health data in Ontario, Canada: Identifying gaps, addressing challenges, and uncovering opportunities

Ali, F., Law, J., Russell, C., Imtiaz, S., Bayoumi, A., Werb, D., Rhem, J., Front. Public Health

Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder: Concordance entre le dépistage de drogues dans l’urine et l’usage autodéclaré dans le contexte d’un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l’usage d’opioïdes vendus sur ordonnance

Bastien G, Abboud A, McAnulty C, Mahroug A, Le Foll B, Socias ME, Juteau LC, Dubreucq S, Jutras-Aswad D., Can J Psychiatry. 2025

The Effect of Opioid Agonist Treatment on Injection-Related Sequelae: A Population-Based Observational Study

Lim J, Bruneau J, Platt RW, Panagiotoglou D., Drug Saf. 2025

“Street sweeps”: The municipal government-enforced confiscation of personal belongings among unstably housed people who use drugs in Vancouver, Canada

Eren IM, Sayre EC, Shane C, P.O.W.E.R., Kelsall TS, Beatrice M, Sudds R, DeBeck K, Milloy MJ, Kerr T, Hayashi K, Public Health

Public support of and attitudes toward decriminalization of possession of illegal drugs among the general population in British Columbia

Imtiaz, S., Russell, C., Ali, F., Elton-Marshall, T., Patenaude, S., and Rehm, J., Substance Abuse Treatment, Prevention, and Policy

Harnessing telemedicine to deliver patient‑centered opioid agonist treatment within a community‑based harm reduction service: a mixed methods evaluation

Stine Bordier Høj, Rémi Coignard‑Friedman, Aissata Sako, Catherine de Montigny, Marie‑Ève Beauchemin‑Nadeau, Robert Léandre, Nanor Minoyan, Geneviève Boyer‑Legault, Sofiane Chougar, Sara‑Kim Lamont, Julie Bruneau, Harm Reduction Journal , 2025

Engagement with and acceptability of telephone-based telemedicine in addiction care in Vancouver, Canada, 2020–2023

Hayashi K, Reading D, Bach P, Choi JC, Hedden L, Milloy MJ, DeBeck K, J Addict Med

Policing and access to harm reduction services among young people who use drugs and young Indigenous people who use drugs before and after the pilot implementation of decriminalization of personal possession

McAdam E, Milloy MJ, Sayre EC, Verdicchio C, Sedgemore K, May H, Pranteau S, Corriveau D, Friesen D, Fleury M, Fast D, DeBeck K, Int J Drug Policy READ MORE

Longitudinal polysubstance use patterns and non-fatal overdose: a repeated measures latent class analysis

Karamouzian M, Cui Z, Hayashi K, DeBeck K, Reddon H, Buxton J, Kerr T, Int J Drug Policy

A pilot randomized controlled trial of a digital cannabis harm reduction intervention for young adults with first-episode psychosis who use cannabis

Coronado-Montoya S, Abdel-Baki A, Bodson-Clermont P, Boucher-Roy D, Côté J, Crocker CE, Crockford D, Daneault JG, Dubreucq S, Dussault-Laurendeau M, Fischer B, Lachance-Touchette P, Lecomte T, L’Heureux S, Ouellet-Plamondon C, Roy MA, Tatar O, Tibbo PG, Villeneuve M, Wittevrongel A, Jutras-Aswad D., Psychiatry Res. 2025

Predicting Fatal Drug Poisoning Among People Living with HIV‑HCV Co‑Infection

Mélanie Bédard, Erica Em Moodie, Joseph Cox, John Gill, Sharon Walmsley, Valérie Martel‑Laferrière, Curtis Cooper, Marina B Klein, Canadian Liver Journal, 2025

Methodology

Quantitative

Publications

Topic

Emergency care

decriminalisation

Harm reduction

Law enforcement/incarceration

Opioid agonist treatment

Prescription monitoring

Psychosocial intervention

Recovery

Sexually transmitted & blood-borne infections

Substance

Alcohol

Cannabis

Injectable drug use

Opioids

Tobacco/nicotine

Stimulants